The Department carefully considers all evidence in the public domain on matters relating to the growth and competitiveness of the UK Life Science sector, including the recent report by WPI Strategy. This happens in combination with broad engagement with individual companies, the NHS and with charities and patient representatives, and will continue in future as part of the delivery of the Government’s Life Science Vision.